D. E. Shaw & Co., Inc. - OSIRIS THERAPEUTICS INC NEW ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of OSIRIS THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2016$692,000
+28.9%
140,978
+30.3%
0.00%0.0%
Q3 2016$537,000
-5.5%
108,170
-3.0%
0.00%0.0%
Q2 2016$568,000
+2.9%
111,558
+15.5%
0.00%0.0%
Q1 2016$552,000
+177.4%
96,621
+404.4%
0.00%
Q4 2015$199,000
-84.5%
19,156
-72.4%
0.00%
-100.0%
Q3 2015$1,284,000
-46.8%
69,495
-44.0%
0.00%
-50.0%
Q2 2015$2,415,000
+106.2%
124,103
+86.3%
0.00%
+100.0%
Q1 2015$1,171,000
+432.3%
66,604
+383.1%
0.00%
Q4 2014$220,000
+32.5%
13,786
+29.4%
0.00%
Q2 2014$166,000
-1.2%
10,653
+2.3%
0.00%
Q4 2013$168,000
-49.2%
10,418
-47.6%
0.00%
-100.0%
Q3 2013$331,000
+71.5%
19,866
+3.4%
0.00%
Q2 2013$193,00019,2090.00%
Other shareholders

There were no reported owners of OSIRIS THERAPEUTICS INC NEW in Q3 2023.

NameSharesValueWeighting ↓
View complete list of OSIRIS THERAPEUTICS INC NEW shareholders